Cognition Therapeutics, Inc. (CGTX)
0.9796
-0.01
(-1.05%)
USD |
NASDAQ |
Sep 10, 16:00
0.95
-0.03
(-3.02%)
After-Hours: 20:00
Cognition Therapeutics Total Liabilities (Quarterly) : 5.872M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.872M |
| March 31, 2026 | 6.229M |
| December 31, 2025 | 14.12M |
| September 30, 2025 | 6.866M |
| June 30, 2025 | 12.59M |
| March 31, 2025 | 11.23M |
| December 31, 2024 | 11.48M |
| September 30, 2024 | 13.10M |
| June 30, 2024 | 11.36M |
| March 31, 2024 | 9.991M |
| December 31, 2023 | 10.69M |
| Date | Value |
|---|---|
| September 30, 2023 | 9.846M |
| June 30, 2023 | 9.574M |
| March 31, 2023 | 9.88M |
| December 31, 2022 | 10.18M |
| September 30, 2022 | 14.24M |
| June 30, 2022 | 8.913M |
| March 31, 2022 | 9.956M |
| December 31, 2021 | 7.864M |
| September 30, 2021 | 100.11M |
| June 30, 2021 | 100.97M |
| March 31, 2021 | 84.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 85.06M |
| Bristol Myers Squibb Co. | 65.32B |
| Structure Therapeutics, Inc. | 71.01M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.90M |
| Shareholders Equity (Quarterly) | 33.02M |
| Debt to Equity Ratio | 0.0178 |
| Current Ratio | 7.027 |
| Net Debt Paydown Yield | -0.02% |